Skip to main content
. 2009 May;4(5):957–964. doi: 10.2215/CJN.00010109

Table 2.

Treatment characteristics and clinical outcomes of PD-associated peritonitis caused by Pseudomonas or other organisms in Australia, 2003 through 2006. Results are expressed as number (%) or median days [interquartile range]a

Outcome Pseudomonas Peritonitis (n = 191 Episodes) Non-Pseudomonas Peritonitis (n = 3403 Episodes) P
Treatment
    change to second antibiotic regimen (n [%]) 126 (66) 1884 (55) 0.005
    time to second antibiotic regimen (d; median [IQR]) 2.00 (1.00 to 4.00) 3.00 (2.00 to 5.00) 0.030
    change to third antibiotic regimen (n [%]) 48 (25) 449 (13) <0.001
    time to third antibiotic regimen (d; median [IQR]) 6.00 (4.00 to 11.00) 7.00 (4.00 to 10.00) 0.400
    total antibiotic treatment duration (d; median [IQR]) 16.00 (9.75 to 23.00) 14.00 (8.00 to 19.00) 0.001
Relapse (n [%]) 17 (9) 485 (14) 0.040
Hospitalization
    n (%) 150 (79) 2354 (69) 0.006
    duration (d; median [IQR]) 9.00 (5.00 to 20.00) 6.00 (3.00 to 11.00) <0.001
Catheter removal
    n (%) 84 (44) 691 (20) <0.001
    time to occurrence (d; median [IQR]) 5.50 (3.00 to 11.00) 6.00 (3.00 to 13.00) 0.400
Temporary hemodialysis
    n (%) 20 (10) 132 (4) <0.001
    time to occurrence (d; median [IQR]) 7.50 (4.25 to 12.50) 6.00 (3.00 to 11.50) 0.500
    duration (d; median [IQR]) 73.50 (51.00 to 109.50) 67.00 (20.50 to 103.00) 0.300
Permanent hemodialysis
    n (%) 66 (35) 569 (17) <0.001
    time to occurrence (d; median [IQR]) 6.00 (4.00 to 11.75) 7.00 (4.00 to 13.00) 0.700
Death
    n (%) 6 (3) 76 (2) 0.400
    time to death (d; median [IQR]) 19.00 (5.00 to 26.00) 11.00 (3.00 to 22.25) 0.400
a

IQR, interquartile range.